## Core Concept
The use of oral contraceptive pills (OCPs) has been associated with various health benefits beyond contraception, including protection against certain types of malignancies. The relationship between OCPs and cancer risk is complex and varies by type of cancer.

## Why the Correct Answer is Right
Oral contraceptive pills are known to protect against **endometrial cancer** and **ovarian cancer**. The protective effect against endometrial cancer is thought to be due to the progestin component, which helps to regulate the growth of the endometrium, reducing the risk of malignant transformation. For ovarian cancer, the mechanism is less clear but may involve reduction in the number of ovulations, thereby decreasing the chance of genetic mutations in ovarian epithelial cells. However, OCPs have been associated with a slightly increased risk of **breast cancer**, particularly during use and for a short period after stopping, but this risk seems to return to normal over time after discontinuation.

## Why Each Wrong Option is Incorrect
- **Option A: Endometrial cancer** - OCPs are known to protect against endometrial cancer, so this option is incorrect as it is a malignancy that OCPs protect against.
- **Option B: Ovarian cancer** - Similarly, OCPs protect against ovarian cancer, making this option incorrect for the same reason.
- **Option D: Colorectal cancer** - There is evidence suggesting that long-term use of OCPs may reduce the risk of colorectal cancer, although the mechanism is not well understood.

## Why Option C is Correct
- **Option C: Breast cancer** - While the relationship is complex and there might be a slight increase in risk during and shortly after use, the question seems to focus on protective effects. Notably, the protective effects against endometrial, ovarian, and possibly colorectal cancers are more straightforward compared to the slightly increased or complex relationship with breast cancer.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the protective effects of OCPs against endometrial and ovarian cancers are significant and long-lasting, even after stopping the pills. However, the impact on breast cancer risk is more nuanced, with a potential slight increase in risk during and immediately after use.

## Correct Answer: C. Breast cancer